DOWNLOAD REQUEST – FCF LIFE SCIENCES RESEARCH SERIES
FCF Life Sciences engages in research on recent financing trends in the Life Sciences sector, i.e. biotechnology, pharma and med-tech. FCF primarily focuses on the latest activities in the equity capital markets: Venture Capital, Initial Public Offerings (IPO) and Equity Valuations.
The findings are regularly published in:
NEWS & PRESS

FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 08/2023 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 08/2023”. The Monitor is a monthly published overview of venture capital trends in the European
Venture Capital Sentiment Tracker – July 2023
July 2023: Biotechnology Medical Technology Health Technology Funding Volume (€m) 0 Trend Funding Volume (€m) 0 Trend Funding Volume (€m) 0 Trend Biotechnology Funding Volume (€m) 0 Trend Medical Technology Funding Volume (€m) 0 Trend

FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 07/2023 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 07/2023”. The Monitor is a monthly published overview of venture capital trends in the European

FCF Biotech Venture Capital Monitor – USA 06/2023 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 06/2023”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As
Venture Capital Sentiment Tracker – June 2023
June 2023: Biotechnology Medical Technology Health Technology Funding Volume (€m) 0 Trend Funding Volume (€m) 0 Trend Funding Volume (€m) 0 Trend Biotechnology Funding Volume (€m) 0 Trend Medical Technology Funding Volume (€m) 0 Trend